A child with erythropoietic protoporphyria (EPP) — marked by skin hypersensitivity to sunlight and sometimes artificial light — underwent cardiac surgery with minimal issues due to a blood exchange protocol that prevented photosensitivity effects and potential hemolysis, or the destruction of red blood cells, according to a recent case…
Alpha-lipoic acid, an insulin sensitizer, may help improve the breakdown and use of glucose, or blood sugar, in the liver of patients with acute intermittent porphyria (AIP), according to a recent cell-based study. The findings showed that alpha-lipoic acid is “attractive for the management of metabolic disorders, as it…
Long-term treatment with Givlaari (givosiran) is safe and provides sustained clinical benefits to people with acute hepatic porphyria (AHP), according to an interim, two-year analysis of a Phase 3 trial’s ongoing extension, presented at a science conference. These data are in line with previous trial findings, showing that the…
Get regular updates to your inbox.